Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections licensed in the UK — Mounjaro (tirzepatide) and Wegovy (semaglutide) — are taken once a week, every seven days, on a day you choose and keep consistent. That's the answer, and it surprises a lot of people who expect something more complex. These are prescription-only medicines, so the exact schedule a prescriber sets for you may be tailored to your situation, but the licensed dosing rhythm is the same for both: one injection per week, same day each week. If you're weighing up whether this is the right option, a free consultation with our prescribers is the place to start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common assumption our prescribers encounter is that a stronger or quicker result must mean more frequent injections. It doesn't. Mounjaro and Wegovy are both engineered to release slowly in the body over seven days, which is precisely why once a week works. Giving an extra dose mid-week wouldn't accelerate the effect, it would raise the risk of side effects without any clinical benefit.
This design also makes the practical side more manageable. You pick a day (Tuesday morning, Sunday evening, whatever fits your week) and you stick to it. Consistency matters more than which day you choose. If you'd like a fuller picture of the injection routine itself, the injection frequency guide on our site walks through the specifics.
The other thing worth correcting: these medicines are not the same as B12 injections, which follow a completely different schedule and serve a different purpose. If you've been reading about B12 injection schedules, the comparison is understandable but the two are not interchangeable. Mounjaro and Wegovy are GLP-1 medicines with a licensed once-weekly dosing programme set by clinical trial evidence and MHRA approval.
Understanding this rhythm is the foundation of using these treatments safely. The NHS tirzepatide page offers a reliable, plain-English overview of what the treatment involves.
Starting low is deliberate. Mounjaro begins at 2.5mg, not because that dose does much for appetite directly, but because it lets your digestive system settle before moving to doses that genuinely affect how hungry you feel. The prescriber then increases the dose roughly every four weeks, watching for tolerability. The titration schedule for weight loss injections isn't a race; slowing down at a particular step is clinically sensible if nausea is an issue.
Wegovy follows a similar pattern: doses step up through 0.5mg, 1.0mg, 1.7mg and then 2.4mg, each roughly four weeks apart. The recently approved 7.2mg maintenance dose, cleared by the MHRA in early 2026, gives semaglutide a higher ceiling for eligible patients, though that level is only reached after the full titration sequence under prescriber guidance.
A practical habit worth building from week one: mark your injection day in your phone's calendar with a recurring reminder set for the same time. That single check, taking under a minute to set up, removes the most common reason people accidentally miss a dose or inject too soon.
Throughout the titration, the pen itself stays once-weekly. The frequency doesn't change; the strength does. That distinction matters if you're comparing what you've read on different sites, because confusion between dose and frequency is widespread. For questions about the weekly dosing schedule from a practical angle, we've covered that separately.
Nausea is the most commonly reported side effect, and it tends to peak in the day or two after an injection, particularly after a dose step-up. Knowing this, many people choose to inject on a day when a slower morning the next day doesn't cause problems, a Friday evening works well for some, not at all for others who'd rather not feel off during the weekend. There's no clinically superior day; it's about fitting your life.
The practical side of using these drugs involves a few basics worth knowing early: clean the injection site, use a fresh needle each time, dispose of used pens and needles in an appropriate sharps container, and never reuse a needle. These aren't optional hygiene steps; they're part of using the treatment correctly.
If you experience severe or persistent stomach pain that seems to spread toward your back, seek medical help promptly. The MHRA has highlighted acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines, it's rare, but the symptom pattern is specific enough to take seriously. You can report any suspected side effect via the MHRA Yellow Card scheme.
The frequency of injections also intersects with some other medications. Women taking an oral contraceptive pill should discuss this with their prescriber when starting Mounjaro specifically, because delayed gastric emptying can affect how well oral medicines are absorbed in the early weeks of treatment.
Using weight loss injections isn't just about remembering a weekly appointment with your fridge. These are prescription-only medicines, which means a clinician assesses your suitability before you start and reviews your progress before every repeat supply. At nume, a GPhC-registered prescriber reads your consultation on the same day you submit it, a real clinician, not a software filter.
That clinical relationship is what makes the weekly rhythm safe rather than just convenient. Dose increases are confirmed by a prescriber reviewing your response, not auto-generated. You can explore the wider range of weight loss treatment options we offer, and for a clear picture of what's included in the cost of private treatment, the weight loss injection pricing page sets it all out plainly. If you have questions before committing to anything, our frequently asked questions cover the most common ones.
According to NICE's appraisal of tirzepatide (TA1026), treatment should be reviewed at six months: if weight loss is less than 5% at the highest tolerated dose, continuing may not be appropriate. That's a clinician's conversation, not a rule you navigate alone.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.